Hüfner M, Döhner H, Schmidt J, Möller P, Ho A D, Hunstein W
Medizinische Klinik und Poliklinik V (Haematologie/Onkologie/Rheumatologie), Universität Heidelberg.
Klin Wochenschr. 1989 Apr 3;67(7):402-7. doi: 10.1007/BF01711269.
A patient with peripheral T-cell Lymphoma and acquired, systemic osteosclerosis is described. Bone histology showed a spectacular activation of osteoblasts accompanyed by massive new bone formation. Alkaline phosphatase in serum was elevated and increased to greater than 2000 U/l when the lymphoma became refractory to chemotherapy. In the patient's serum an osteoblast-activating factor could be demonstrated using a rat osteogenic osteosarcoma cell line (ROS 17/2.8). The factor was absent during remission of the tumor. We conclude that osteosclerosis was a paraneoplastic syndrome in this patient due to the secretion of an osteoblast-stimulating factor by the T-cell lymphoma. This situation is similar to the secretion of osteoclast-activating factors described in B-cell lymphomas, particularly multiple myeloma. The characterization of such a factor could be of therapeutic relevance.
本文描述了一名患有外周T细胞淋巴瘤并伴有获得性全身性骨硬化症的患者。骨组织学显示成骨细胞显著活化,并伴有大量新骨形成。血清碱性磷酸酶升高,当淋巴瘤对化疗产生耐药时,其水平升高至大于2000 U/l。使用大鼠成骨肉瘤细胞系(ROS 17/2.8)可在患者血清中检测到一种成骨细胞活化因子。在肿瘤缓解期该因子不存在。我们得出结论,由于T细胞淋巴瘤分泌成骨细胞刺激因子,骨硬化症在该患者中是一种副肿瘤综合征。这种情况类似于B细胞淋巴瘤尤其是多发性骨髓瘤中所描述的破骨细胞活化因子的分泌。对这种因子的特性进行鉴定可能具有治疗意义。